Blow to Glenmark: HC restrains it from making anti-diabetes drugs
In a blow to Indian drug firm Glenmark Pharmaceuticals, Delhi High Court Wednesday restrained it from making, selling, advertising, distributing or exporting its anti-diabetes drugs Zita and Zita-Met on the ground that it violated the patent of US pharma major Merck Sharp and Dohme (MSD).
Oct 07, 2015, 22:26 PM IST
HC restrains Glenmark from business of anti-diabetes drugs
In a relief for US drug major Merck Sharp and Dohme (MSD), Delhi High Court on Wednesday restrained Indian firm Glenmark Pharmaceuticals from manufacturing and selling its anti-diabetes drugs Zita and Zita-Met, saying it has infringed patent of the American company.
Oct 07, 2015, 12:16 PM IST
